Beren Therapeutics Secures $300M Financing to Support the Potential Commercial Launch of Adrabetadex and Long-Term Care Initiatives for Infantile-Onset Niemann-Pick Disease, Type C

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Beren Therapeutics P.B.C., the parent company of Mandos LLC and a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, today announced it has secured $300 million in combined financing. The financing includes a $135 million equity financing alongside up to $165 million in a strategic financing facility with Hercules Capital, Inc. (NYSE: HTGC) across a senior secured debt and royalty structure. Capital will support Beren's growth.

Business Wire • Jun 10, 2026

Hercules Capital: Attractive Valuation And Growth Potential

Hercules Capital is a strong buy, trading at a rare 28.4% NAV premium versus its 5-year average of 49.36%. HTGC offers a 12.3% dividend yield, with distributions well covered by net investment income and supported by $149.1M in spillover income. The portfolio is conservatively structured, with 98% floating-rate senior secured loans and non-accruals at just 0.1% of fair value.

Seeking Alpha • Jun 9, 2026

Hercules Capital (HTGC) Down 7.4% Since Last Earnings Report: Can It Rebound?

Hercules Capital (HTGC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Jun 4, 2026

My Dividend Stock Portfolio: New April Dividend Record - 100 Holdings With 5 Buys

April net investment activity reached a multi-year low as rising stock valuations and BDC sector weakness prompted a cautious approach and selective BDC purchases. Focused April allocations on Ares Capital, Blue Owl Capital, and Hercules Capital, yielding a 7.5% average on new investments despite sector headwinds. Dividend income set a modest April record at $990, up 3% year-over-year, with BDCs contributing 27% of Q2 year-to-date dividends but facing potential further cuts.

Seeking Alpha • May 27, 2026

The High-Yield Stocks the Smart Money Is Buying Right Now

There is a principle I have followed for 30 years in this business. When the smartest credit team on the planet starts aggressively buying a beaten-down asset class they understand better than anyone alive, you do not sit on your hands and debate whether the timing is perfect.

Benzinga • May 24, 2026

Hercules Capital: Buy The Dip On This 12% BDC Yield

Hercules Capital (HTGC) now trades at 1.2x NAV, offering a compelling entry point for income-focused investors. HTGC maintains a robust, internally managed portfolio with a 12% dividend yield, supported by stable net investment income and disciplined underwriting. Recent valuation compression reflects market concerns over AI-driven disruption in software, but only a third of HTGC's portfolio is exposed.

Seeking Alpha • May 22, 2026

6 High-Yielding BDCs Safe Enough for Dividend Investors

It has been a scary few months for the sector, but the worst may be over. Here are sex BDC that offer exceptional dividend durability.

Barrons • May 21, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hercules Capital, Inc. of Class Action Lawsuit and Upcoming Deadlines – HTGC

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hercules Capital, Inc. (“Hercules” or the “Company”) (NYSE: HTGC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

GlobeNewsWire • May 19, 2026

NYHTGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Hercules Capital, Inc. Securities Lawsuit - Contact The Gross Law Firm

NEW YORK, May 19, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hercules Capital, Inc. (NYSE: HTGC). Shareholders who purchased shares of HTGC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

PRNewsWire • May 19, 2026

Portnoy Law Firm Announces Class Action on Behalf of Hercules Capital, Inc. Investors

LOS ANGELES, May 19, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hercules Capital, Inc., (“Hercules” or the "Company") (NYSE: HTGC) investors of a class action on behalf of investors that bought securities between May 1, 2025 and January 27, 2026, inclusive (the “Class Period”). Hercules investors have until May 21, 2026 to file a lead plaintiff motion.

GlobeNewsWire • May 19, 2026